Condition
Bronchoalveolar Lavage (BAL)
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Not Yet Recruiting1
Completed1
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07627594Not Yet Recruiting
Safety of Bronchoscopy in Patients With Interstitial Lung Disease
NCT06815666Phase 2Recruiting
BAL Fluid Biomarkers in Sarcoma
NCT07130110Not ApplicableCompletedPrimary
BAL Contribution to Lung Cryo-TBB in ILD
NCT04502368Unknown
Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients
Showing all 4 trials